Clinical trial costs are spiraling out of control. Studies generally estimate the cost of bringing an Investigational new drug (IND) to market at $1B although there is considerable variability in such estimates. Data handling and pickup costs related to patient records account for a staggering 30 percent of drug development costs. This is just the beginning of the cost of non-compliance – for more details, refer to “Medication Non-Compliance”, “How Valid Are Your Clinical Trials Data?” and “Are Patient Reports Accurate?”
NFC Forum Certified
IMC, the global leader in Smart Medication Adherence Solutions, is proud to announce that our Electronic Content Monitoring NFC Tag is the world's only Medication Adherence Device certified and listed by NFC Forum.
Our Electronic Content Monitors (ECMs) provide valuable and objective insights into medication adherence; we provide NFC Forum-certified devices, HIPAA cloud platform, apps and helpdesk services.
Our connected adherence devices are designed with the patient in mind. Our innovative medication technologies are available for blister packs, pill bottles, syringes and custom formats.
Did you know?
Utilizing NFC-connected smart adherence packaging optimizes your clinical decisions by improving data accuracy.